EVERSANA INTOUCH’s annual trends paper looks ahead on the horizon in 2023 in pharma marketing.
As the economy ebbs and flows, pharma and biotech companies alike are feeling the pressure to cut costs. From rapid inflation to the ever-changing regulatory landscape, many are looking for ways to reduce their burn rate.
As a result of surging electricity costs, Europe’s drugmakers have warned they may stop making some cheap generic medicines and are calling for an overhaul of the way they are priced. The industry is just the latest to seek help as the energy crisis deepens.
The number of births in the United States grew 1% in 2021 from a pandemic low in 2020, marking the first increase since 2014, according to a report by the U.S. Centers for Disease Control and Prevention (CDC).